| Dr Melvin Juan Velazquez Munoz, MD | |
|
Humacao Medical Plaza, Oficina 203 Calle Font Martelo H53, Humacao, PR 00791 | |
| (787) 365-1999 | |
| (787) 285-1970 |
| Full Name | Dr Melvin Juan Velazquez Munoz |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | Humacao Medical Plaza, Humacao, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861547101 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 9849 (Puerto Rico) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 9849 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melvin Juan Velazquez Munoz, MD Humacao Medical Plaza, Oficina 203 Calle Font Martelo H53, Humacao, PR 00791 Ph: (787) 365-1999 | Dr Melvin Juan Velazquez Munoz, MD Humacao Medical Plaza, Oficina 203 Calle Font Martelo H53, Humacao, PR 00791 Ph: (787) 365-1999 |
News Archive
It will be increasingly difficult for protein molecules to remain anonymous, and increasingly easy for doctors and patients to detect the early stages of latent diseases. Researchers at the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw and the University of North Texas in Denton have perfected a method of producing thin detecting films that are able to recognize specific proteins.
PamLab L.L.C., developer and marketer of Metanx®, announced today that the results of a study to determine if nutritional management with Metanx® improves numbness in the feet of patients with Diabetic Neuropathy (DN) was published in the fourth quarter 2010 issue of Reviews in Neurological Diseases. The study demonstrated that Metanx®, a medical food available by prescription, promotes restoration of lost cutaneous sensation in DN patients.
UPV/EHU researchers have developed a method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate.This method will help not only in the more effective early detection of this cancer, but also in the development of more personalised treatments.
Chevy Chase, MD-Patients with type 2 diabetes are generally treated similarly despite the fact that they may have underlying differences that could affect their therapeutic response. Seeking to address this critical health issue, an international multidisciplinary group of experts just issued recommendations for individualized treatment in a consensus statement to be published in the April 2010 issue of the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
› Verified 8 days ago